Results 131 to 140 of about 10,820,757 (182)

Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer. [PDF]

open access: yesJ Clin Oncol
Ando Y   +15 more
europepmc   +1 more source

A Significant Increase in the Serum Carbohydrate Antigen 19-9 Level Accompanied by Acute Cholecystitis and Choledocholithiasis: A Case Report and Review of the Literature. [PDF]

open access: yesIntern Med
Kawaguchi T   +9 more
europepmc   +1 more source

Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study. [PDF]

open access: yesInt J Surg
Li XL   +25 more
europepmc   +1 more source

Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125

International Journal of Urology, 2005
Abstract  We report a case of advanced renal pelvis and ureter adenocarcinoma producing carcinoembryonic antigen (CEA), carbohydrate antigen 19‐9 (CA19‐9) and carbohydrate antigen 125 (CA125). A 72‐year‐old woman was diagnosed with right renal pelvic and ureter tumor with para‐aortic lymph node swelling.
Yoshiki Sugimura   +2 more
exaly   +3 more sources

Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)

Clinical Chemistry and Laboratory Medicine (CCLM), 2006
AbstractClin Chem Lab Med 2006;44:1137–9.
Mario, Berth   +6 more
openaire   +2 more sources

Primary Adenocarcinoma of the Ureter Producing Carbohydrate Antigen 19-9

The Journal of Urology, 1996
A 62-year-old man was hospitalized with a history of intermittent hematuria. Excretory urography showed a delayed left nephrogram. Although cytological evaluation of urine indicated transitional cell carcinoma, cystoscopy revealed no visible tumor. Retrograde pyelography on the left side demonstrated a 1.5 cm.
H, Iwaki   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy